MedTrace Logo

Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Post Approval Registry

NCT01294449 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 394

Last updated 2014-12-04

Study results available
· View outcomes & findings →

Summary

MADIT-CRT PAR is an FDA mandated follow-up registry for patients that participated in the MADIT-CRT IDE study examining long-term mortality.

(MADIT-CRT IDE: NCT00180271)

Conditions

Interventions

DEVICE

MADIT-CRT ICD

Patients that were randomized to the the implantable cardioverter defibrillator (ICD) device for the study.

DEVICE

MADIT-CRT CRT-D

Patients that were randomized to the the cardiac resynchronization therapy with defibrillation (CRT-D) device for the study.

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Arthur J Moss, MD · University of Rochester Heart Research Follow-up Program

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2013-10-31
Completion
2013-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01294449 on ClinicalTrials.gov